Skip to content

â??COMPARATIVE STUDY OF THE THERAPEUTIC EFFICACY OF GLYCOLIC ACID PEEL AND Q-SWITCHED LASER IN MELASMAâ??

â??COMPARATIVE STUDY OF THE THERAPEUTIC EFFICACY OF GLYCOLIC ACID PEEL (35%-50%) AND LOW FLUENCE (1064nm) Q-SWITCHED Nd:YAG LASER IN MELASMAâ??

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/08/003935
Enrollment
40
Registered
2013-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Melasma

Interventions

Intervention1: Q-switched Nd:YAG laser: Group B will have 4 sessions of low fluence (1064nm) Q-switched Nd:YAG laser also done at 2 weekly intervals for a period of 8 weeks Intervention2: Glycolic

Sponsors

Dr NINON PATRAO
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients 18 yrs of age and above and of either sex • Patients who have received any topical treatment, however after a wash out period of 2 weeks

Exclusion criteria

Exclusion criteria: • Patients less than 18 yrs • Patients who have received prior treatment in the form of lasers or chemical peels • Patients on oral contraceptives,pregnant and lactating women • Patients with endocrinological or systemic illness or hypersensitivity to chemical peel • Patients not willing for the study

Design outcomes

Primary

MeasureTime frame
â?¢ To explore the effectiveness and safety of glycolic acid peel (35%-50%) and low fluence (1064nm) Q-Switched Nd:YAG laser in melasma â?¢ To compare the efficacy of the two modalities Timepoint: 2 weeks,4 weeks,6 weeks and 8 weeks

Secondary

MeasureTime frame
â?¢ To compare the efficacy of the two modalitiesTimepoint: 2 weeks,4 weeks,6 weeks and 8 weeks

Countries

India

Contacts

Public ContactDr JACINTHA MARTIS

Father Muller Medical College

dr_martisj@yahoo.co.in9845148112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026